| 23rd Dec 2021 2:19 pm |
RNS |
Holding(s) in Company |
| 21st Dec 2021 5:05 pm |
RNS |
Holding(s) in Company |
| 8th Dec 2021 7:00 am |
RNS |
Data Presented at ESWI Influenza Conference |
| 6th Dec 2021 5:30 pm |
RNS |
Holding(s) in Company |
| 6th Dec 2021 7:00 am |
RNS |
Synairgen Presents SNG001 Data at ESWI |
| 19th Nov 2021 2:26 pm |
RNS |
Holding(s) in Company |
| 11th Nov 2021 7:00 am |
RNS |
Synairgen completes Phase III recruitment |
| 8th Nov 2021 12:58 pm |
RNS |
Holding(s) in Company |
| 26th Oct 2021 3:13 pm |
RNS |
Holding(s) in Company |
| 21st Oct 2021 5:39 pm |
RNS |
Holdings in Company |
| 21st Oct 2021 7:00 am |
RNS |
Grant of Options |
| 20th Oct 2021 7:00 am |
RNS |
SNG001 progresses to Phase 3 of ACTIV-2 trial |
| 13th Oct 2021 7:00 am |
RNS |
Synairgen appoints Gareth Walters, Ph.D. as CRO |
| 5th Oct 2021 11:25 am |
RNS |
Holding(s) in Company |
| 30th Sep 2021 7:02 am |
RNS |
Non-Executive Director Appointment |
| 30th Sep 2021 7:00 am |
RNS |
Interim results |
| 21st Sep 2021 7:00 am |
RNS |
Synairgen Notice of Interim Results |
| 10th Sep 2021 11:30 am |
RNS |
Holding(s) in Company |
| 12th Aug 2021 4:12 pm |
RNS |
Exercise of Options and Total Voting Rights |
| 6th Aug 2021 12:21 pm |
RNS |
Holding(s) in Company |
| 29th Jun 2021 4:28 pm |
RNS |
Holding(s) in Company |
| 18th Jun 2021 10:29 am |
RNS |
Result of AGM |
| 7th Jun 2021 7:00 am |
RNS |
Grant of Options |
| 25th May 2021 4:28 pm |
RNS |
Notice of AGM |
| 24th May 2021 7:00 am |
RNS |
Results of in vitro studies |
| 12th May 2021 7:00 am |
RNS |
Full Year Results |
| 30th Apr 2021 7:00 am |
RNS |
Home Cohort data of SG016 Phase II trial |
| 16th Apr 2021 4:37 pm |
RNS |
Holding(s) in Company |
| 15th Apr 2021 11:44 am |
RNS |
Holding(s) in Company |
| 6th Apr 2021 4:36 pm |
RNS |
Holding(s) in Company |
| 15th Feb 2021 7:00 am |
RNS |
Dosing commenced in US ACTIV-2 trial |
| 25th Jan 2021 7:00 am |
RNS |
Inclusion in US ACTIV-2 trial |
| 20th Jan 2021 7:00 am |
RNS |
Home trial recruitment completed |
| 13th Jan 2021 7:00 am |
RNS |
First Patient Dosing in Phase III SG018 Trial |
| 6th Jan 2021 5:10 pm |
RNS |
Holding(s) in Company |
| 5th Jan 2021 5:53 pm |
RNS |
Holding(s) in Company |
| 18th Dec 2020 7:00 am |
RNS |
COVID-19 Clinical Programme Update |
| 10th Dec 2020 12:57 pm |
RNS |
Holding(s) in Company |
| 13th Nov 2020 5:03 pm |
RNS |
Holding(s) in Company |
| 13th Nov 2020 7:00 am |
RNS |
Lancet Respiratory Medicine publishes Phase 2 data |
